Key result
Integrating the fatty liver index and fibrotic NASH index with a polygenic risk score model significantly improved the accuracy of diagnosing dyslipidemia, achieving an AUROC of 0.704.
Why the study?
Current prediction models relying solely on dyslipidemia polygenic risk scores have limitations, prompting validation of NAFLD and NASH indexes combined with PRS.
Does combining the fatty liver index and fibrotic NASH index with a polygenic risk score improve the prediction of dyslipidemia in South Korean adults?
Cohort (n=48,263)
Does combining the fatty liver index and fibrotic NASH index with a polygenic risk score improve the prediction of dyslipidemia in South Korean adults?
Integrating fatty liver and fibrotic NASH indices with a polygenic risk score significantly improves the predictive accuracy for dyslipidemia, particularly in East Asian men.
Answers are grounded in this paper and cite their sources.
May enhance sex-specific dyslipidemia risk stratification in East Asians; extends PRS models with NAFLD indexes but leaves clinical adoption open.
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are recognized risk factors for dyslipidemia. Current prediction models that rely solely on dyslipidemia polygenic risk score (PRS) have certain limitations. We aimed to validate simple indexes for NAFLD and NASH as predictors of dyslipidemia using the PRS. This study utilized cohort data from an urban population-based dataset comprising 48,263 South Koreans. The incidence of dyslipidemia was higher in men than in women (32.4% and 27.8%; p < 0.001). The PRS model predicted dyslipidemia more accurately in men (AUROC [95% confidence intervals]: 0.645 [0.636-0.754]). Notably, integrating the fatty liver index (FLI) and fibrotic NASH index (FNI) with the PRS model resulted in the highest accuracy in diagnosing dyslipidemia, particularly in men (AUROC [95% confidence intervals]: 0.704 [0.698-0.711]). In conclusion, a predictive model combining the PRS with FLI and FNI was validated. This model offers more accurate predictive value for diagnosing dyslipidemia, particularly in East Asian men. Thus, our study has the clinical potential for identifying high-risk individuals and determining preventive measures for dyslipidemia in a sex-specific manner.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted a cohort in Dyslipidemia (n=48,263). Polygenic risk score combined with fatty liver index and fibrotic NASH index vs. Polygenic risk score alone was evaluated on Accuracy in diagnosing dyslipidemia (AUROC) (95% CI 0.698-0.711, p=<0.001). Integrating the fatty liver index and fibrotic NASH index with a polygenic risk score model significantly improved the accuracy of diagnosing dyslipidemia, achieving an AUROC of 0.704.
Synapse has enriched 10 related papers. Consider them for comparative context: